Roger S. McIntyre
Affiliations: | Mood Disorders Psychopharmacology Unit | University Health Network, Toronto, Toronto, Ontario, Canada |
Google:
"Roger McIntyre"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Yena Lee | grad student | 2016- | University of Toronto |
| Elisa Brietzke | grad student | 2017-2017 | University Health Network, Toronto |
| Rodrigo Barbachan Mansur | post-doc | University Health Network, Toronto |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Le GH, Kwan ATH, Guo Z, et al. (2024) Impact of vortioxetine on depressive symptoms moderated by symptoms of anxiety in persons with post-COVID-19 condition: A secondary analysis. Psychiatry Research. 339: 116068 |
| Badulescu S, Tabassum A, Le GH, et al. (2024) Glucagon-like peptide 1 agonist and effects on reward behaviour: A systematic review. Physiology & Behavior. 283: 114622 |
| McIntyre RS, Mansur RB, Rosenblat JD, et al. (2024) The association between ketamine and esketamine and suicidality: reports to the Food And Drug Administration Adverse Event Reporting System (FAERS). Expert Opinion On Drug Safety. 1-6 |
| Teopiz KM, Kwan ATH, Le GH, et al. (2024) Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis. Current Medical Research and Opinion. 1-7 |
| McIntyre RS, Wong S, Kwan ATH, et al. (2024) Association between dual orexin receptor antagonists (DORAs) and suicidality: reports to the united states food and drug administration adverse event reporting system (FAERS). Expert Opinion On Drug Safety |
| Kwan ATH, Rosenblat JD, Mansur RB, et al. (2024) The association between ketamine and esketamine with alcohol and substance misuse: Reports to the Food and Drug Administration adverse event reporting system (FAERS). Journal of Affective Disorders. 360: 421-426 |
| Wong S, Le GH, Kwan ATH, et al. (2024) Risk of VMAT2 inhibitors on suicidality and parkinsonism: report utilizing the United States Food and Drug Administration adverse event reporting system. International Clinical Psychopharmacology |
| Lam RW, Kennedy SH, Adams C, et al. (2024) Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437241245384 |
| McIntyre RS, Agid O, Biesheuvel E, et al. (2024) Effect of venlafaxine on anhedonia and amotivation in patients with major depressive disorder. Cns Spectrums. 29: 206-214 |
| Wong S, Le GH, Phan L, et al. (2024) Effects of anhedonia on health-related quality of life and functional outcomes in major depressive disorder: A systematic review and meta-analysis. Journal of Affective Disorders. 356: 684-698 |